Ahmad Masri, MD, MS, on the Potential of Cell Therapy in Light Chain Amyloidosis
For World Amyloidosis Day, the cardiologist at the Center for Hypertrophic Cardiomyopathy at Oregon Health & Science University discussed how Nexcella’s NXC-201 could help address unmet needs.
Ahmad Masri, MD, MS, on the Potential of Gene Therapy in ATTR Amyloidosis
In observance of World Amyloidosis Day, the cardiologist at the Center for Hypertrophic Cardiomyopathy at Oregon Health & Science University discussed the changing landscape of care in this field.